Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Guangzhou Wondfo Biotech Co., Ltd. currently manages 1 pending office action within the Chemistry & Materials technology area. This action is assigned to 1 distinct examiner, LE, AUSTIN Q, who also serves as the busiest examiner for the portfolio. The prosecution is localized within 1 distinct art unit, which suggests a specific focus for the company's current patent applications. Having 1 distinct examiner and 1 distinct art unit involved means the applicant can focus on a consistent strategy without navigating different examiner styles.
LE, AUSTIN Q is responsible for 1 busiest examiner pending office action, making this individual the primary point of contact at the office. For practitioners, this centralized oversight simplifies communication and allows for a direct negotiation process. The Chemistry & Materials field involves specialized technical requirements, and having 1 distinct examiner provides an opportunity to build a focused legal argument. The administrative requirements for 1 pending office action are specific to this single matter. This structure allows for a dedicated allocation of resources toward achieving a successful outcome.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LE, AUSTIN Q | 1 | 49.7% | +31.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263418 | BIOLOGICAL PARTICLE SORTING CHANNEL AND MICROFLUIDIC CHIP | LE, AUSTIN Q | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263418 | BIOLOGICAL PARTICLE SORTING CHANNEL AND MICROFLUIDIC CHIP | LE, AUSTIN Q | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18263418 | BIOLOGICAL PARTICLE SORTING CHANNEL AND MICROFLUIDIC CHIP | LE, AUSTIN Q | 1796 | §103§112 | Final Rejection | 4d overdue | Pending | Jul 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial